PPBT
Purple Biotech
PPBT
PPBT
8 hedge funds and large institutions have $390K invested in Purple Biotech in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$41K | |
| 2 | +$21K | |
| 3 | +$20K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.8K |
| 5 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
+$1K |
Top Sellers
| 1 | -$110K | |
| 2 | -$57K | |
| 3 | -$24K | |
| 4 |
MC
Menta Capital
San Francisco,
California
|
-$14.3K |
| 5 |
MIFH
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
|
-$1K |